化学名称: (2S,3S,4S,5R,6S)-6-((3-(2-(((4-Carbamimidoylphenyl)amino)methyl)-1-methyl-N-(pyridin-2-yl)-1H-benzo[d]imidazole-5-carboxamido)propanoyl)oxy)-3,4,5-trihydroxytetrahydro-2H-pyran-2-carboxylic acid
微笑: CN1C2=CC=C(C(N(C3=CC=CC=N3)CCC(O[C@@H]([C@@H]([C@@H](O)[C@@H]4O)O)O[C@@H]4C(O)=O)=O)=O)C=C2N=C1CNC5=CC=C(C(N)=N)C=C5
印地语: InChI=1/C15H14N2O4/c16-15(21)17-11-4-2-1-3-9(11)13(19)14(20)10-7-8(18)5-6-12(10)17/h1-7,13-14,18-20H,(H2,16,21)/p+1
Novel method for separation and quantification of potential impurities by RP-HPLC from KSM stage to API stage of dabigatran mesylate
By Jhansi, T. Naga; Nagaraju, R.; Kumar, D. Jaya Deep; Rao, G. Nageswara
From International Journal of Pharmaceutical Sciences and Research (2021), 12(3), 1762-1779
Development and Validation of RP-UPLC Method for the Determination of Process and Degradant Impurities Present in Dabigatran Etexilate Mesylate Capsules Using High Strength Silica-T3 Sorbent Column
By Mantena, Bhaskara P. V.; Rao, Sumathi V.; Suryakala, D.; Ramakrishna, K.; Srikanth Reddy, R.
From Analytical Chemistry Letters (2016), 6(5), 595-611
Determination of dabigatran etexilate mesylate by HPLC
By Jia, Ling-xiao; Tang, Lei; Zhang, Shu-ting; Song, Rui-zhi; Gao, Zhan-wen
From Shipin Yu Yaopin (2015), 17(3), 195-197